Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
NCT01160029
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Nateglinide
Sponsor
Dr. Reddy's Laboratories Limited